Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jun 11, 2026
Reporting period
Not applicable
Filed with the SEC
Jun 16, 2026
DirectorGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001437749-26-020708
Filed / recorded
Jun 16, 2026, 4:14 AM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
PUMA BIOTECHNOLOGY, INC.
Issuer CIK
1401667
Ticker
PBYI
Reporting person
Brian M Stuglik
Relationship
Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Jun 11, 2026
Transaction code
A
Shares / units
27,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
121,958
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.